Search | Clinical Trials Finder

Conditions: Obesity, Type 2 Diabetes Mellitus
Interventions: Laboratory evaluations, sleep study, Best Medical Management, Roux-en-Y gastric bypass surgery; Other · Procedure
Lead sponsor: David Bradley MD; Other
Eligibility: 25 Years to 70 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Perfusion; Complications
Interventions: Image surgical area; Device
Lead sponsor: Christie Medical Holdings, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Englewood, New Jersey

Conditions: Intracerebral Hemorrhage
Interventions: MIS+Cathflo Activase (drug), Intraoperative stereotactic CT-Guided Endoscopic Surgery; Drug · Procedure
Lead sponsor: Daniel Hanley; Other
Eligibility: 18 Years to 80 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2013
U.S. locations: 26
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 19 more

Conditions: Herniorrhaphy, Abdominoplasty
Interventions: Customizable Dressing with ActiV.A.C. Therapy Unit, Standard of Care Dressing; Device
Lead sponsor: KCI USA, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 2
States / cities: Miami, Florida • Pittsburgh, Pennsylvania

Conditions: Glaucoma
Interventions: Ranibizumab; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 21 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Total Joint Arthroplasty, Pain, Postoperative
Interventions: Mobile Education Delivery, Standard Verbal and Written Education; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Oropharyngeal Squamous Cell Cancer
Interventions: Neck Dissection, Standard-of-Care (SOC) Transoral Surgery of Primary Site, SOC Radiation, SOC Carboplatin, SOC Paclitaxel, Videofluoroscopy; Procedure · Radiation · Drug
Lead sponsor: University of Michigan Rogel Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Breast Cancer
Interventions: Urine sample, Electrode sleep recorder, phlebotomy; Procedure · Device
Lead sponsor: Stanford University; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 141 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Stanford, California

Conditions: Peripheral Arterial Disease (PAD), Amputation, Thrombosis, Thrombosis (Stent Thrombosis), Platelet Aggregation Inhibitors, Thromboelastography (TEG), PRU(Platelet Reactivity Unit)
Interventions: Aspirin, Clopidogrel, Ticagrelor, Rivaroxaban, Thromboelastography with Platelet Mapping; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 484 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts • Salem, Massachusetts

Conditions: Cancer
Interventions: Targeted agent, Standard of care agent; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Breast Cancer
Interventions: blood draw; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Endoscopic Submucosal Dissection
Interventions: Endoscopic Submucosal Dissection; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 3
States / cities: Gainesville, Florida • Boston, Massachusetts • Houston, Texas

Conditions: Congenital Heart Disease in Children, Hypoxia, Neurodevelopmental Disorders, Complex Congenital Heart Disease
Interventions: Single Arm, Neonatal Neurobehavioral Scale; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 0 Years to 52 Years · Female only
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 5
States / cities: San Francisco, California • Washington D.C., District of Columbia • Scarborough, Maine + 1 more

Conditions: Bowel Dysfunction
Interventions: Bowel Surgery with Metronidazole; Procedure
Lead sponsor: Duke University; Other
Eligibility: 0 Years to 2 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Perilunate Injury
Interventions: Arthroscopic surgery, Open Surgery; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Pain
Interventions: lidocaine hydrochloride; Drug
Lead sponsor: Lahey Clinic; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Burlington, Massachusetts

Conditions: Deep Vein Thrombosis of Lower Limb, Pulmonary Embolism (PE), Bleeding
Interventions: ActiveCare CECT device, Enoxaparin; Device · Drug
Lead sponsor: Medical Compression Systems; Industry
Eligibility: 18 Years and older
Enrollment: 411 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 9
States / cities: La Jolla, California • Loma Linda, California • Los Angeles, California + 6 more

Conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Interventions: Biospecimen Collection, Computed Tomography, Durvalumab, Patient Observation, Questionnaire Administration; Procedure · Biological · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 306 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2039
U.S. locations: 280
States / cities: Jonesboro, Arkansas • Beverly Hills, California • Dublin, California + 223 more

Conditions: Urinary Retention, Uterine Prolapse
Interventions: Spinal anesthesia, General anesthesia; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years and older · Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Cataract
Interventions: Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic, Bromfenac 0.075% Oph Solution; Drug
Lead sponsor: Carolina Eyecare Physicians, LLC; Other
Eligibility: 50 Years to 99 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Colonic Diseases, Rectal Diseases
Interventions: Bipolar electrosurgical generator and instruments, Disposable stapling instruments; Procedure
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Cystic Fibrosis
Interventions: Iontophoresis sweat test; Device
Lead sponsor: Polychrome Medical, Inc.; Industry
Eligibility: Not listed
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 6
States / cities: Birmingham, Alabama • Chicago, Illinois • Ann Arbor, Michigan + 3 more

Conditions: Opioid Use, Pain, Post Operative
Interventions: nCAP Signal Relief Patch, Standard of Care; Device · Other
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Lung Cancer
Interventions: educational intervention, medical chart review, questionnaire administration, end-of-life treatment/management, psychosocial assessment and care, quality-of-life assessment, management of therapy complications, assessment of therapy complications; Other · Procedure
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Duarte, California

Search by objective public record fields.

Metabolic Surgery Versus Medical Management for Resolution of Type II Diabetes

Evaluation of Tissue Oxygen Levels During Breast Reconstruction With a New Surgical Device

Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

Mobile Educations Effect on Pain Outcomes

Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer

Sleep, Circadian Hormonal Dysregulation, and Breast Cancer Survival

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Multi-center Evaluation of the Clinical Utility of ESD in the Western Population

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Perioperative Tissue Penetration of Antimicrobials in Infants

Perilunate Management

Pilot Study About Safety and Efficacy of Atomized Intrapleural Lidocaine During Pleuroscopy

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Does Spinal Anesthesia for Prolapse Surgery With Lead to Urinary Retention?

Prophylactic Treatment: Lessdrops™ vs Standard Drops Regimen

Random Comparison of LigaSure and Disposable Staples for Laparoscopic Surgery

A Multi-Center Study of the CF Quantum® Sweat Test System

A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery

Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery